13-94443759-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001922.5(DCT):c.1180-122A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.75 in 723,948 control chromosomes in the GnomAD database, including 210,952 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).
Frequency
Genomes: 𝑓 0.76 ( 45436 hom., cov: 31)
Exomes 𝑓: 0.75 ( 165516 hom. )
Consequence
DCT
NM_001922.5 intron
NM_001922.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.633
Genes affected
DCT (HGNC:2709): (dopachrome tautomerase) Predicted to enable dopachrome isomerase activity. Involved in response to blue light. Located in intracellular membrane-bounded organelle and plasma membrane. Implicated in oculocutaneous albinism. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.809 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DCT | ENST00000377028.10 | c.1180-122A>G | intron_variant | 1 | NM_001922.5 | ENSP00000366227.4 | ||||
DCT | ENST00000446125.1 | c.1279-122A>G | intron_variant | 1 | ENSP00000392762.1 | |||||
DCT | ENST00000483392.6 | n.*55-122A>G | intron_variant | 5 | ENSP00000431275.2 |
Frequencies
GnomAD3 genomes AF: 0.764 AC: 116087AN: 152008Hom.: 45398 Cov.: 31
GnomAD3 genomes
AF:
AC:
116087
AN:
152008
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.746 AC: 426733AN: 571822Hom.: 165516 AF XY: 0.744 AC XY: 223740AN XY: 300864
GnomAD4 exome
AF:
AC:
426733
AN:
571822
Hom.:
AF XY:
AC XY:
223740
AN XY:
300864
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.764 AC: 116170AN: 152126Hom.: 45436 Cov.: 31 AF XY: 0.755 AC XY: 56121AN XY: 74348
GnomAD4 genome
AF:
AC:
116170
AN:
152126
Hom.:
Cov.:
31
AF XY:
AC XY:
56121
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1746
AN:
3476
ClinVar
Significance: association
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Age related macular degeneration 7 Other:1
association, no assertion criteria provided | research | School of Pharmacy, University of Eastern Finland | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at